Could common gout pills influence dementia risk?
NCT ID NCT04746989
Summary
This study looked back at existing Medicare records to see if taking certain gout medications (probenecid or allopurinol) was linked to a different risk of developing Alzheimer's or other dementias. It analyzed data from nearly 300,000 older adults with gout but no prior dementia. The goal was to gather information, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
Conditions
Explore the condition pages connected to this study.